APOE and glomerulosclerosis: Similarly, SGLT2i and acarbose demonstrated effects beyond their glucose‐lowering potential by lowering the incidence of atherosclerosis in diabetic ApoE −/− mice with the former, and that of lung tumors, liver degeneration, and glomerulosclerosis with the latter (Han et al., 2017; Harrison et al., 2019; Liu et al., 2021).